CVD May Increase Risk of Cognitive Decline in Older Women

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
A relationship between cardiovascular disease (CVD) and cognitive decline in postmenopausal women was identified in a recent study published online in the Journal of the American Heart Association. In women without CVD, hypertension and diabetes increased the risk for cognitive decline. No significant relationship was found between atrial fibrillation and heart failure with cognitive functioning.

To read the full article at HCPLive.com, click here
Related Articles
Pharmacist-driven drug management programs best ensure atrial fibrillation patients adhere to the warfarin alternative, dabigatran (Pradaxa).
Abbott’s new blood glucose meter is now widely available OTC without insurance co-pays.
Today’s approval of Amgen’s ivabradine makes it the first new chronic heart failure medicine that has been approved by the FDA in almost a decade.
The lack of generic insulin may keep patients from using the medicine, even though they risk life-threatening complications, new research from Johns Hopkins University School of Medicine suggests.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$